Pediatric inflammatory myofibroblastic tumor with late metastasis to the lung: Case report and review of the literature

被引:43
作者
Morotti, RA
Legman, MD
Kerkar, N
Pawel, BR
Sanger, WG
Coffin, CM
机构
[1] Mt Sinai Med Ctr, Dept Pathol, New York, NY 10029 USA
[2] Mt Sinai Med Ctr, Recanati Miller Transplant Inst, New York, NY 10029 USA
[3] Mt Sinai Med Ctr, Div Hepatol, New York, NY 10029 USA
[4] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[5] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[6] Nebraska Med Ctr, Munroe Mayer Inst, Human Genet Labs, Dept Pediat & Pathol, Omaha, NE USA
[7] Univ Utah, Sch Med, Dept Pediat Pathol, Salt Lake City, UT USA
关键词
inflammatory myofibroblastic tumor; inflammatory fibrosarcoma; extrapulmonary inflammatory myofibroblastic tumor; metastasis; children;
D O I
10.1007/s10024-004-8088-5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Inflammatory myofibroblastic tumors (IMTs) are challenging lesions with respect to classification, differential diagnosis, and biologic potential. In children, extrapulmonary IMTs, particularly those from the abdomen or mesentery, are generally aggressive, with frequent local recurrences. There are few documented patients with distant metastasis, and most of these had metastases at presentation or developed metastases within months to a few years. We add to the short list of metastatic extrapulmonary IMTs a pediatric patient in whom the primary lesion was widespread in the abdomen at presentation and metastatic disease to the lung was diagnosed 9 years after the primary resection. We describe the clinical and pathologic features of this patient and review the characteristics of extrapulmonary IMTs with distant metastasis reported in the literature.
引用
收藏
页码:224 / 229
页数:6
相关论文
共 16 条
[1]  
Biselli R, 1996, CANCER, V77, P778, DOI 10.1002/(SICI)1097-0142(19960215)77:4<778::AID-CNCR25>3.0.CO
[2]  
2-X
[3]   ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor [J].
Coffin, CM ;
Patel, A ;
Perkins, S ;
Elenitoba-Johnson, KSJ ;
Perlman, E ;
Griffin, CA .
MODERN PATHOLOGY, 2001, 14 (06) :569-576
[4]   EXTRAPULMONARY INFLAMMATORY MYOFIBROBLASTIC TUMOR (INFLAMMATORY PSEUDOTUMOR) - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF 84 CASES [J].
COFFIN, CM ;
WATTERSON, J ;
PRIEST, JR ;
DEHNER, LP .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1995, 19 (08) :859-872
[5]  
Coffin CM, 2002, WHO CLASSIFICATION T, P91
[6]   Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor - A comparative immunohistochemical study [J].
Cook, JR ;
Dehner, LP ;
Collins, MH ;
Ma, ZG ;
Morris, SW ;
Coffin, CM ;
Hill, DA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (11) :1364-1371
[7]   Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor [J].
Debelenko, LV ;
Arthur, DC ;
Pack, SD ;
Helman, LJ ;
Schrump, DS ;
Tsokos, M .
LABORATORY INVESTIGATION, 2003, 83 (09) :1255-1265
[8]  
Hagenstad CT, 2003, ARCH PATHOL LAB MED, V127, P865
[9]  
HASEGAWA SL, 1998, PATHOL CASE REV, V3, P128
[10]  
Hussong JW, 1999, MODERN PATHOL, V12, P279